Treatment With Imatinib Prevents Fibrosis in Different Preclinical Models of Systemic Sclerosis and Induces Regression of Established Fibrosis

Arthritis & Rheumatism
doi 10.1002/art.24186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2015English

Semaphorin4A Coordinately Induces Inflammation and Fibrosis in Systemic Sclerosis

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

FRI0419 Intravenous Immunoglobulins Prevents Experimental Fibrosis in a Murine Model of Systemic Sclerosis

2018English

Adjunct Treatment of Recalcitrant Hand Plaques in Nephrogenic Systemic Fibrosis After Imatinib Therapy

SKIN The Journal of Cutaneous Medicine
2019English

Vascular Endothelial Growth Factor Aggravates Fibrosis and Vasculopathy in Experimental Models of Systemic Sclerosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances

Frontiers in Immunology
AllergyImmunology
2018English

548 Inhibitory Regulation of MFG-E8 on Fibrosis in Systemic Sclerosis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Integrin-Modulating Therapy Prevents Fibrosis and Autoimmunity in Mouse Models of Scleroderma

Nature
Multidisciplinary
2013English

Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis

Current Rheumatology Reviews
Rheumatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy